Results 31 to 40 of about 4,673,795 (354)

Determinants of patient‐reported xerostomia among long‐term oropharyngeal cancer survivors

Cancer, 2021
This study was conducted to identify clinicodemographic risk factors for xerostomia among long‐term oropharyngeal cancer (OPC) survivors.
P. Aggarwal, K. Hutcheson, A. Garden, F. Mott, Charles Lu, R. Goepfert, C. Fuller, S. Lai, G. Gunn, M. Chambers, E. Sturgis, E. Hanna, S. Shete   +12 more
semanticscholar   +1 more source

Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial.

Journal of the National Cancer Institute, 2021
BACKGROUND Patients with human papillomavirus-related oropharyngeal cancers have excellent outcomes but experience clinically significant toxicities when treated with standard chemoradiotherapy (70 Gy).
N. Riaz, E. Sherman, X. Pei, H. Schöder, M. Grkovski, R. Paudyal, N. Katabi, P. Selenica, Takafumi N. Yamaguchi, D. Ma, Simon S. K. Lee, Rachna Shah, Rahul Kumar, F. Kuo, A. Ratnakumar, Nathan Aleynick, David N. Brown, Zhigang Zhang, V. Hatzoglou, Lydia Y. Liu, A. Salcedo, C. J. Tsai, S. McBride, L. Morris, J. Boyle, Bhuvanesh Singh, D. Higginson, R. Damerla, A. Paula, K. Price, E. Moore, Joaquín J. García, R. Foote, A. Ho, R. Wong, T. Chan, S. Powell, P. Boutros, J. Humm, A. Shukla-Dave, D. Pfister, J. Reis-Filho, N. Lee   +42 more
semanticscholar   +1 more source

A Contemporary Systematic Review on Repartition of HPV-Positivity in Oropharyngeal Cancer Worldwide

Viruses, 2021
Significant variation in human papillomavirus (HPV) prevalence in oropharyngeal squamous cell carcinoma (OPSCC) across countries ranging from 11% in Brazil to 74% in New Zealand has been reported earlier.
A. Carlander, K. Jakobsen, S. K. Bendtsen, Martin Garset-Zamani, C. D. Lynggaard, J. S. Jensen, Christian Grønhøj, C. Buchwald   +7 more
semanticscholar   +1 more source

Estimated Cost of Circulating Tumor DNA for Posttreatment Surveillance of Human Papillomavirus–Associated Oropharyngeal Cancer

JAMA Network Open, 2022
This cross-sectional study compares the cost and effectiveness of 3 posttreatment strategies for surveillance of human papillomavirus (HPV)–associated oropharyngeal cancer.
R. Kowalchuk, B. K. Kamdem Talom, K. V. Van Abel, Daniel M. Ma, M. Waddle, D. Routman   +5 more
semanticscholar   +1 more source

Usefulness of circulating tumor DNA by targeting human papilloma virus-derived sequences as a biomarker in p16-positive oropharyngeal cancer

Scientific Reports, 2022
In head and neck cancer, early detection of recurrence after treatment is important. The contemporary development of therapeutic agents have improved the prognosis after recurrence; however, no biomarker has been established for evaluating therapeutic ...
K. Akashi, Toshihiko Sakai, Osamu Fukuoka, Yuki Saito, Masafumi Yoshida, Mizuo Ando, Takeshi Ito, Yoshinori Murakami, T. Yamasoba   +8 more
semanticscholar   +1 more source

Extrachromosomal DNA in HPV-Mediated Oropharyngeal Cancer Drives Diverse Oncogene Transcription

Clinical Cancer Research, 2021
Purpose: Human papillomavirus (HPV) plays a major role in oncogenesis and circular extrachromosomal DNA (ecDNA) is found in many cancers. However, the relationship between HPV and circular ecDNA in human cancer is not understood.
John Pang, Nam Nguyen, J. Luebeck, Laurel L. Ball, A. Finegersh, Shuling Ren, Takuya Nakagawa, Mitchell Flagg, S. Sadat, P. Mischel, Guorong Xu, K. Fisch, T. Guo, Gabrielle L Cahill, B. Panuganti, V. Bafna, J. Califano   +16 more
semanticscholar   +1 more source

Evaluation of Malnutrition and Quality of Life in Patients Treated for Oral and Oropharyngeal Cancer

TheScientificWorldJournal, 2021
Background Oral and oropharyngeal cancer is a debilitating disease with high morbidity and mortality. Depending on the site and extent of the involvement of the cancer and the type of treatment modality, these patients can develop pain, trismus ...
Shruthi Pingili, J. Ahmed, Nanditha Sujir, N. Shenoy, R. Ongole   +4 more
semanticscholar   +1 more source

Lack of knowledge regarding HPV and its relation to oropharyngeal cancer among medical students

Cancer Reports, 2021
Oropharyngeal cancer (OPC) is an important cause of cancer‐related mortality. Early detection of OPC results in a favorable prognosis and higher survival rates.
Malik Sallam, D. Dababseh, A. Yaseen, A. Al-Haidar, Hajar Ettarras, Dania Jaafreh, Hanan Hasan, Khaled Al-Salahat, Esraa Al-Fraihat, Y. Hassona, G. O. Şahin, A. Mahafzah   +11 more
semanticscholar   +1 more source

Metastatic model of HPV+ oropharyngeal squamous cell carcinoma demonstrates heterogeneity in tumor metastasis [PDF]

, 2016
Human papillomavirus induced (HPV+) cancer incidence is rapidly rising, comprising 60–80% of oropharyngeal squamous cell carcinomas (OPSCCs); while rare, recurrent/metastatic disease accounts for nearly all related deaths.
Coppock, Joseph D, Lee, John H, Lee, Kimberly M, Onken, Michael D, Spanos, William C, Uppaluri, Ravindra, Vermeer, Daniel W, Vermeer, Paola D, Zeng, Erliang   +8 more
core   +2 more sources

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

Hepatology, EarlyView., 2022
Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou, Yongkun Sun, Wen Zhang, Jiajia Yuan, Zhi Peng, Wei Wang, Jifang Gong, Lin Yang, Yanshuo Cao, Hong Zhao, Chao Chen, Weifeng Wang, Lin Shen, Aiping Zhou   +13 more
wiley   +1 more source